scispace - formally typeset
C

Catherine Van Der Straeten

Researcher at Imperial College London

Publications -  26
Citations -  1210

Catherine Van Der Straeten is an academic researcher from Imperial College London. The author has contributed to research in topics: Arthroplasty & Hip resurfacing. The author has an hindex of 11, co-authored 24 publications receiving 857 citations. Previous affiliations of Catherine Van Der Straeten include Ghent University & Ghent University Hospital.

Papers
More filters
Journal ArticleDOI

Cobalt toxicity in humans—a review of the potential sources and systemic health effects

TL;DR: Future research should focus on longitudinal studies in the clinical setting of MoM hip implant patients to further elucidate the dose-response discrepancies, and monitoring of the free fraction of Co2+ might be advisable for future risk assessment.
Journal ArticleDOI

The 2012 Otto Aufranc Award: The Interpretation of Metal Ion Levels in Unilateral and Bilateral Hip Resurfacing

TL;DR: Metal levels higher than these proposed safe upper limits can predict problems with metal-on-metal resurfacings and are important parameters in the management of at-risk patients.
Journal ArticleDOI

A New Prediction Model for Patient Satisfaction After Total Knee Arthroplasty

TL;DR: A new prediction tool for patient satisfaction following TKA may allow surgeons and patients to evaluate the risks and benefits of surgery on an individual basis and help in patient selection.
Journal ArticleDOI

Revisions of metal-on-metal hip resurfacing: lessons learned and improved outcome

TL;DR: Malpositioning of the components with associated wear-induced soft tissue fluid collections was the most frequent factor leading to failure of a hip resurfacing arthroplasty.
Journal ArticleDOI

Meniscal Allograft Transplantation Does Not Prevent or Delay Progression of Knee Osteoarthritis.

TL;DR: MAT did not delay or prevent tibiofemoral OA progression and patients younger than 35 with no-to-mild cartilage damage may benefit from MAT for relief of symptoms, but patients and healthcare payers and providers should be aware of the high number of surgical re-interventions.